Salicylic acid derivatives as potential α-glucosidase inhibitors: drug design, molecular docking and pharmacokinetic studies

Bulletin of the National Research Centre

Table 7 ADMET properties of the designed analogues

	Absorption	Distribution	CNS	Metabolism							Excretion	Toxicity
	Intestinal absorption (Human)	BBB perm. (Log BB)	Perm. (Log PS)	Substrate and inhibitors CYP							Total clearance	AMES toxicity
				Substrate of CYP		Inhibitors of CYP
				2D6	3A4	1A2	2C19	2C9	2D6	3A4
A1	92.552	− 0.756	− 2.072	No	Yes	No	Yes	Yes	No	Yes	0.007	No
A2	93.752	− 0.896	− 1.949	No	Yes	No	Yes	Yes	No	Yes	0.110	No
A3	92.024	− 0.756	− 2.026	No	Yes	No	Yes	Yes	No	Yes	− 0.229	No
A4	92.961	− 0.921	− 1.881	No	Yes	No	Yes	Yes	No	Yes	− 0.367	No
A5	92.024	− 0.773	− 2.026	No	Yes	No	Yes	Yes	No	Yes	− 0.347	No